Christina Heitmueller

Tafasitamab mediates killing of B-cell non-Hodgkin’s lymphoma in combination with γδ T cell or allogeneic NK cell therapy

J. Endell, M. Wilhelm, S. Steidl, 2022, Cancer Immunology, Immunotherapy.